Learn the 5 critical success factors clinical directors need to run multi-site neuroimaging trials—covering protocol standardization, QC, training,...
Learn the key challenges of medical AI validation and how cloud-based platforms streamline AI validation medical imaging workflows for clinical...
RSNA 2025 highlighted a crowded AI landscape—but also the growing complexity of multi-site imaging trials. Learn why scanner variability, protocol...
Take a look ahead at our predicted trends for neuroscience in 2025 - where technology, neuroplasticity, and neuroethics are reshaping the way we...
Is your imaging facility drowning in data? Spot 5 warning signs of poor imaging data management and discover solutions to transform chaos into...
Manual reviews slow studies and add risk. Learn how QMENTA automates imaging review and QC with AI workflows that adapt to any protocol.
AI pioneer Dr. John E. Kelly III shares insights on building trust, improving data, and driving progress in AI-enabled neurological trials.
Parkinson’s Disease (PD) is the second most prevalent neurodegenerative disorder worldwide. Over 750 industry clinical trials have been initiated for...
Learn how QMENTA simplifies central vein detection in Multiple Sclerosis. Our solution automates protocol adherence, sequence recognition, and white...